Objective: Evaluation of sarcopenia and fragility and possible nutritional therapy.
Criteria: age> 65 years, frailty, functional autonomy, MMSE> 24 (no dementia, acute disease, K
in place, endocrinopathies, steroid and heparin therapy)
Assessment: T0 (sampling + MOC + DXA + psycho / neuro / cognitive tests)